Regardless of when you quit, smoking impacts gene expression in a way that increases the risk of cardiovascular disease, among other conditions. 

Medtronic announced new data, demonstrating safety and efficacy at three years in acute complicated Type B aortic dissection patients treated with the Valiant Captivia Thoracic Stent Graft System. Ali Azizzadeh, MD, FACS, University of Texas Health Science Center in Texas presented the new clinical data in a late-breaking trial session at Vascular Interventional Advances (VIVA) 2016.

SOUTH SAN FRANCISCO, Calif., Sept. 21, 2016 (GLOBE NEWSWIRE) -- MyoKardia, Inc. (Nasdaq:MYOK), a clinical stage biopharmaceutical company pioneering a precision medicine approach for the treatment of heritable cardiovascular diseases, will highlight today the expected path to registration for its lead product candidate MYK-461 in the initial indication of symptomatic oHCM and its plans to progress MYK-491 into the clinic for DCM.

LOMA LINDA, CA., September 20, 2016 – Loma Linda University researcher Gordon G. Power, together with a team of researchers from several other universities, has received a patent from the U.S. Patent and Trademark Office for the use of nitrite salts to treat specific cardiovascular conditions. The discovery was made through ongoing research and with government support under Grant Nos. HL58091 and HL70146, awarded by the NIH.

Shockwave Medical, a pioneer in the treatment of calcified cardiovascular disease, today announced clearance from the U.S. Food and Drug Administration (FDA) of the Lithoplasty System for the treatment of calcified plaque in patients with peripheral artery disease (PAD).

SANTA ROSA, Calif. – September 14, 2016 – Claret Medical®, an innovator in filter-based cerebral embolic protection technologies, today announced that data from its SENTINEL pivotal IDE trial has been accepted for the Late-Breaking Clinical Trial session at the 28th Transcatheter Cardiovascular Therapeutics (TCT), the annual scientific symposium of the Cardiovascular Research Foundation, being held October 29 to November 2 in Washington, DC.

COLUMBIA, Md., Sept. 13, 2016 (GLOBE NEWSWIRE) -- Digital health technology leader WellDoc announced today it has entered a commercial partnership agreement withLifeScan Inc., one of the Johnson & Johnson Diabetes Care Companies (JJDCC) and a world leader in blood glucose monitoring, to deliver across the United States a best-in-class digital health solution for Type 2 diabetes.

Broomfield, CO, Sept. 13, 2016 (GLOBE NEWSWIRE) -- Colibri Heart Valve LLC, a privately held emerging medical device company focused on structural heart applications, has entered into definitive documents with Venus Medtech (Hangzhou) Inc., the preeminent Chinese transcatheter heart valve company, to establish a joint venture. Under the terms of the agreement, Colibri and Venus Medtech will share in the ownership and management of a newly created joint venture entity (JVE) formed to develop and commercialize structural heart valve products for the Chinese and emerging Asia markets.